Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $341.11 million. The enterprise value is $139.39 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 217.26 million shares outstanding. The number of shares has increased by 24.14% in one year.
| Current Share Class | 217.26M |
| Shares Outstanding | 217.26M |
| Shares Change (YoY) | +24.14% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 8.79% |
| Owned by Institutions (%) | 58.78% |
| Float | 156.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15,504.80 |
| Forward PS | 18,155.12 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6,335.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.54, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.54 |
| Quick Ratio | 8.29 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,422.55 |
Financial Efficiency
Return on equity (ROE) is -55.13% and return on invested capital (ROIC) is -28.73%.
| Return on Equity (ROE) | -55.13% |
| Return on Assets (ROA) | -27.01% |
| Return on Invested Capital (ROIC) | -28.73% |
| Return on Capital Employed (ROCE) | -50.17% |
| Revenue Per Employee | $96 |
| Profits Per Employee | -$1.12M |
| Employee Count | 229 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
| Income Tax | 443,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.41% in the last 52 weeks. The beta is 0.99, so ALLO's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -53.41% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 51.06 |
| Average Volume (20 Days) | 2,711,660 |
Short Selling Information
The latest short interest is 34.76 million, so 16.00% of the outstanding shares have been sold short.
| Short Interest | 34.76M |
| Short Previous Month | 38.01M |
| Short % of Shares Out | 16.00% |
| Short % of Float | 22.24% |
| Short Ratio (days to cover) | 9.82 |
Income Statement
In the last 12 months, ALLO had revenue of $22,000 and -$257.59 million in losses. Loss per share was -$1.32.
| Revenue | 22,000 |
| Gross Profit | -192.28M |
| Operating Income | -257.48M |
| Pretax Income | -281.93M |
| Net Income | -257.59M |
| EBITDA | -243.84M |
| EBIT | -257.48M |
| Loss Per Share | -$1.32 |
Full Income StatementBalance Sheet
The company has $292.48 million in cash and $90.76 million in debt, giving a net cash position of $201.72 million or $0.93 per share.
| Cash & Cash Equivalents | 292.48M |
| Total Debt | 90.76M |
| Net Cash | 201.72M |
| Net Cash Per Share | $0.93 |
| Equity (Book Value) | 422.18M |
| Book Value Per Share | 1.99 |
| Working Capital | 267.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$200.30 million and capital expenditures -$694,000, giving a free cash flow of -$200.99 million.
| Operating Cash Flow | -200.30M |
| Capital Expenditures | -694,000 |
| Free Cash Flow | -200.99M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,170,372.73% |
| Pretax Margin | -1,168,850.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.14% |
| Shareholder Yield | -24.14% |
| Earnings Yield | -75.52% |
| FCF Yield | -58.92% |
Analyst Forecast
The average price target for ALLO is $9.66, which is 515.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.66 |
| Price Target Difference | 515.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 649.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -2.85 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.85 |
| Piotroski F-Score | 1 |